» Articles » PMID: 28217274

What Influences Treatment Satisfaction in Patients with Personality Disorders? A Naturalistic Investigation in a Hospitalization Setting

Overview
Journal Ment Illn
Publisher Wiley
Specialty Psychiatry
Date 2017 Feb 21
PMID 28217274
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Treatment satisfaction of different mental disorders is still poorly understood, but of high clinical interest. Inpatients of a general psychiatric care hospital were asked to fill out questionnaires on satisfaction and clinical variables at admission and discharge. On the basis of an exploratory approach, differences in treatment satisfaction among diagnostic groups were examined by means of one-way analysis of variance. Potential associated clinical and socio-demographic variables were studied using multi/univariate tests. Patients with personality disorders (n=18) showed a significantly lower treatment satisfaction (ZUF-8, Zurich Satisfaction Questionnaire) and a slightly lower improvement of symptoms (CGI, Clinical Global Impression) and global functioning (GAF, Global Assessment of Functioning scale) than that of other diagnostic groups (n=95). Satisfaction in patients with personality disorders correlated much stronger with the symptom improvement and slightly with the functioning level than in patients without personality disorders. Interestingly, in patients with personality disorders psychopharmacological treatment in general (present versus not present) was independent from satisfaction. This exploratory investigation suggests that a lower satisfaction of patients with personality disorders in a general psychiatric hospital is mainly based on a reduced improvement of the symptoms and of the global functioning level.

Citing Articles

Crisis and acute mental health care for people who have been given a diagnosis of a 'personality disorder': a systematic review.

Maconick L, Ikhtabi S, Broeckelmann E, Pitman A, Barnicot K, Billings J BMC Psychiatry. 2023; 23(1):720.

PMID: 37798701 PMC: 10552436. DOI: 10.1186/s12888-023-05119-7.

References
1.
Gebhardt S, Wolak A, Huber M . Patient satisfaction and clinical parameters in psychiatric inpatients--the prevailing role of symptom severity and pharmacologic disturbances. Compr Psychiatry. 2012; 54(1):53-60. DOI: 10.1016/j.comppsych.2012.03.016. View

2.
Palmer S, Davidson K, Tyrer P, Gumley A, Tata P, Norrie J . The cost-effectiveness of cognitive behavior therapy for borderline personality disorder: results from the BOSCOT trial. J Pers Disord. 2006; 20(5):466-81. PMC: 1852260. DOI: 10.1521/pedi.2006.20.5.466. View

3.
McHugh R, Whitton S, Peckham A, Welge J, Otto M . Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry. 2013; 74(6):595-602. PMC: 4156137. DOI: 10.4088/JCP.12r07757. View

4.
Bos E, van Wel E, Appelo M, Verbraak M . A randomized controlled trial of a Dutch version of systems training for emotional predictability and problem solving for borderline personality disorder. J Nerv Ment Dis. 2010; 198(4):299-304. DOI: 10.1097/NMD.0b013e3181d619cf. View

5.
Loew T, Nickel M, Muehlbacher M, Kaplan P, Nickel C, Kettler C . Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2006; 26(1):61-6. DOI: 10.1097/01.jcp.0000195113.61291.48. View